International Congress Amsterdam 2015

Saturday, 26.09.2015 Sunday, 27.09.2015 Monday, 28.09.2015 Tuesday, 29.09.2015 Wednesday, 30.09.2015		Sponsored symposia: Evening Symposium organised by Novartis Pharma AG: "IgE-mediated asthma: New revelations and future insights" Evening Symposium organised by Boehringer Ingelheim International GmbH: "The challenge of treating uncontrolled asthma on Step 3 and higher: Comparing options" Industry early morning symposium organised by Novartis Pharma AG: "Multidisciplinary approaches in the personalized care of the ALK + NSCLC patient"

Citations should be made in the following way: Authors. Title. Eur Respir J 2015; 46: Suppl. 59, abstract number.

Long-term non-invasive ventilation (NIV) in COPD

Symposium
Chairs: Mark W. Elliott (Leeds, United Kingdom), Thomas Koehnlein (Leipzig, Germany)
Aims: To discuss the controversial topic of NIV for the long-term treatment of COPD patients in terms of the recent results that were generated by randomised controlled studies. These results may change our treatment strategy for these patients in the future.
Target audience: Clinicians, physicians, intensivists, nurses, physiotherapists and respiratory therapists.

Download all media

New RCTs evaluating NIV in stable hypercapnic COPD Michael Dreher (Aachen, Germany)
NIV for preventing hospital admissions for COPD exacerbations Raffaele Scala (Arezzo, Italy)
NIV after acute exacerbation of COPD: results from the Dutch multicentre study Peter J. Wijkstra (Groningen, Netherlands)
Telemedicine in ventilated COPD patients: concept for the future? Michele Vitacca (Gussago, Italy)